ResMed, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7611521078
USD
251.51
0.07 (0.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
Jun'19
Net Sales
5,146.33
4,685.30
4,222.99
3,578.13
3,196.82
2,957.01
2,606.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,146.33
4,685.30
4,222.99
3,578.13
3,196.82
2,957.01
2,606.57
Raw Material Cost
2,136.63
2,076.51
1,909.35
1,584.89
1,388.80
1,269.32
1,144.92
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
12.61
60.05
60.62
22.31
23.99
40.38
36.16
Selling and Distribution Expenses
991.02
917.14
874.00
739.37
670.39
676.69
645.01
Other Expenses
31.87
24.75
22.70
23.13
20.13
16.16
14.45
Total Expenditure (Excl Depreciation)
3,458.93
3,301.18
3,071.00
2,577.84
2,284.47
2,147.95
1,970.59
Operating Profit (PBDIT) excl Other Income
1687.4
1384.1
1152
1000.3
912.4
809.0999999999999
636
Other Income
-4.82
-5.24
1.15
-17.49
-9.79
-23.01
-11.15
Operating Profit (PBDIT)
1,918.38
1,595.09
1,349.67
1,176.64
1,094.08
967.43
775.63
Interest
12.61
60.05
60.62
22.31
23.99
40.38
36.16
Exceptional Items
7.60
-54.03
9.13
0.00
5.09
-12.59
-69.84
Gross Profit (PBDT)
3,009.70
2,608.78
2,313.64
1,993.23
1,808.02
1,687.69
1,461.65
Depreciation
235.81
216.21
196.52
193.84
191.52
181.37
150.79
Profit Before Tax
1,677.57
1,264.80
1,101.66
960.48
883.66
733.09
518.85
Tax
276.84
243.85
204.11
181.05
409.16
111.41
114.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,400.72
1,020.95
897.56
779.44
474.50
621.67
404.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,400.72
1,020.95
897.56
779.44
474.50
621.67
404.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,400.72
1,020.95
897.56
779.44
474.50
621.67
404.59
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
5,967.86
4,864.04
4,129.90
3,360.75
2,885.68
2,497.03
2,072.19
Earnings per share (EPS)
9.51
6.92
6.09
5.3
3.24
4.27
2.8
Diluted Earnings per share
9.51
6.92
6.09
5.3
3.24
4.27
2.8
Operating Profit Margin (Excl OI)
32.79%
29.54%
27.28%
27.96%
28.54%
27.36%
24.4%
Gross Profit Margin
37.18%
31.61%
30.74%
32.26%
33.63%
30.93%
25.69%
PAT Margin
27.22%
21.79%
21.25%
21.78%
14.84%
21.02%
15.52%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Jun 2025 is 9.84% vs 10.95% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Jun 2025 is 37.19% vs 13.75% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Jun 2025 is 20.18% vs 18.67% in Jun 2024

stock-summary

Interest

YoY Growth in year ended Jun 2025 is -79.03% vs -0.83% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Jun 2025 has improved from Jun 2024

Compare Annual Results Of ResMed, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
5,146.33
3,999.01
1,147.32
28.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,146.33
3,999.01
1,147.32
28.69%
Raw Material Cost
2,136.63
1,177.89
958.74
81.39%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
12.61
0.00
12.61
Selling and Distribution Expenses
991.02
1,763.19
-772.17
-43.79%
Other Expenses
31.87
36.42
-4.55
-12.49%
Total Expenditure (Excl Depreciation)
3,458.93
3,305.29
153.64
4.65%
Operating Profit (PBDIT) excl Other Income
1,687.39
693.73
993.66
143.23%
Other Income
-4.82
-33.87
29.05
85.77%
Operating Profit (PBDIT)
1,918.38
782.93
1,135.45
145.03%
Interest
12.61
0.00
12.61
Exceptional Items
7.60
-28.94
36.54
126.26%
Gross Profit (PBDT)
3,009.70
2,821.12
188.58
6.68%
Depreciation
235.81
145.03
90.78
62.59%
Profit Before Tax
1,677.57
608.96
1,068.61
175.48%
Tax
276.84
187.60
89.24
47.57%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,400.72
421.36
979.36
232.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,400.72
421.36
979.36
232.43%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,400.72
421.36
979.36
232.43%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
5,967.86
3,851.99
2,115.87
54.93%
Earnings per share (EPS)
9.51
5.62
3.89
69.22%
Diluted Earnings per share
9.51
5.62
3.89
69.22%
Operating Profit Margin (Excl OI)
32.79%
16.80%
0.00
15.99%
Gross Profit Margin
37.18%
18.85%
0.00
18.33%
PAT Margin
27.22%
10.54%
0.00
16.68%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 514.63 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 9.84% vs 10.95% in Jun 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 140.07 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 37.19% vs 13.75% in Jun 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 192.32 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is 20.18% vs 18.67% in Jun 2024

Annual - Interest
Interest 1.26 Million
in Jun 2025

Figures in Million
stock-summary

YoY Growth in year ended Jun 2025 is -79.03% vs -0.83% in Jun 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.79%
in Jun 2025

Figures in %
stock-summary

YoY Growth in year ended Jun 2025 has improved from Jun 2024